These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: TCM-based new drug discovery and development in China.
    Author: Wu WY, Hou JJ, Long HL, Yang WZ, Liang J, Guo DA.
    Journal: Chin J Nat Med; 2014 Apr; 12(4):241-50. PubMed ID: 24863348.
    Abstract:
    Over the past 30 years, China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval. The regulatory system for new drug evaluation and registration in China was gradually developed in accordance with international standards. The approval and registration of TCM in China became as strict as those of chemical drugs and biological products. In this review, TCM-based new drug discovery and development are introduced according to the TCM classification of nine categories.
    [Abstract] [Full Text] [Related] [New Search]